BSEVivanza Biosciences Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 18 Dec, 2025 · 14:34 IST

Pursuant to Regulation 30(2) of SEBI, LODR Regulations, 2015 and SEBI Circular Dated November 11, 2024 the members have approved, by Special Resolution through Postal Ballot the alteration ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.0%Reaction day
₹2.03
prior close
₹2.05
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+1.3% vs market
Pharmaceuticals peers, median of 152sector-0.5%+1.4% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.0-0.3+1.3-0.5+1.4
Next day
+5.4+0.9+4.5+0.5+4.9
2d
+0.5+2.3-1.8+1.0-0.5
3d
+3.0+2.4+0.6+1.1+1.9
4d
+2.5+1.8+0.6+0.9+1.5
5d
+5.9+1.3+4.6+0.5+5.4
1w
+5.4+0.4+5.0-0.3+5.7
15d
+11.8-1.1+12.9-0.4+12.2
1m
+5.9-3.3+9.3-2.7+8.6
2m
+5.9-0.5+6.4-2.4+8.3
3m
-5.9-8.2+2.3-9.0+3.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivanza Biosciences has received shareholder approval, via a Special Resolution through postal ballot, to amend its Memorandum of Association. The company is adding a new sub-clause to its Main Objects allowing it to enter the plastic and flexible packaging business. This new line includes manufacturing and trading plastic polymer films (25 microns), plastic bags and sacks made from polyethylene and polypropylene, paper bags with or without plastic coating, and other flexible packaging materials for food, chemicals, fertilizers, and consumer goods. The move signals a strategic diversification beyond the company's existing biosciences operations into the packaging sector. The amendments are subject to approvals from the Ministry of Corporate Affairs and other regulatory bodies.

Likely market impact

This is a business diversification move that could open a new revenue stream in the packaging industry, but it represents a significant shift from the company's core biosciences focus and execution capability remains to be seen. Investors should watch for further updates on actual implementation and capital allocation plans.